UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epigenetic Analysis of Small Cell Lung Cancer Defines Distinct Disease Subsets

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S65-S66

2014

Volltextzugriff (PDF)

A Prospective Study of FDG-PET Imaging in Assessment of Response to Therapy in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma Undergoing Salvage Chemotherapy and Autologous Stem Cell Transplant

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S553-S554

2010

Volltextzugriff (PDF)

DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2

Oncogene, 2015-11, Vol.34 (48), p.5869-5878

2015

Volltextzugriff (PDF)

Impact of TWIST1 Transactivation Domain towards Oncogene-Induced Senescence Suppression in Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e376-e377

2024

Volltextzugriff (PDF)

Investigating the Role of TNIK in the Pathogenesis of Lung Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e355-e356

2024

Volltextzugriff (PDF)

1787P Intracranial response in patients (pts) with baseline (BL) brain metastases (BM) and extensive-stage (ES) small cell lung cancer (SCLC) treated with ifinatamab deruxtecan (I-DXd) in the IDeate-Lung01 study

Annals of oncology, 2024-09, Vol.35, p.S1062-S1063

2024

Volltextzugriff (PDF)

P2.16-06 A Phase 2 Study of Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Previously Treated ES-SCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S377

2023

Volltextzugriff (PDF)

1550TiP Phase II, multicenter, randomized, open-label study of DS-7300 in patients (pts) with pre-treated extensive-stage small cell lung cancer (ES-SCLC)

Annals of oncology, 2022-09, Vol.33, p.S1255-S1256

2022

Volltextzugriff (PDF)

OA04.03 Ifinatamab Deruxtecan (I-DXd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Interim Analysis of Ideate-lung01

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S15-S16

2024

Volltextzugriff (PDF)

Epigenetic Analysis of Small Cell Lung Cancer Defines Distinct Disease Subsets: Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S65-S66

2014

Volltextzugriff (PDF)

Preliminary safety and efficacy of rovalpituzumab tesirine in patients with delta-like protein 3-expressing advanced solid tumors

Annals of oncology, 2017-09, Vol.28, p.v145-v145

2017

Volltextzugriff (PDF)

Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis

ESMO open, 2024-01, Vol.9 (1), p.102199, Article 102199

2024

Volltextzugriff (PDF)

Phase I/II Study to Assess the Safety, Pharmacokinetics (PK) and Efficacy of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Carboplatin/Etoposide in Patients with Solid Tumors Including Small-Cell Lung Cancer (SCLC)

Annals of oncology, 2012-09, Vol.23, p.ix498

2012

Volltextzugriff (PDF)

1543TiP - Phase I/II Study to Assess the Safety, Pharmacokinetics (PK) and Efficacy of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Carboplatin/Etoposide in Patients with Solid Tumors Including Small-Cell Lung Cancer (SCLC)

Annals of oncology, 2012-09, Vol.23, p.ix498-ix498

2012

Volltextzugriff (PDF)

Intragenic Suppressors of Mutant DNA Topoisomerase I-induced Lethality Diminish Enzyme Binding of DNA

The Journal of biological chemistry, 1998-11, Vol.273 (47), p.31519-31527

1998

Volltextzugriff (PDF)

Recovery of respiratory ciliary function after depression by inhalation anaesthetic agents: an in vitro study using nasal turbinate explants

British journal of anaesthesia : BJA, 1996-06, Vol.76 (6), p.854-859

1996

Volltextzugriff (PDF)

An investigation into the effects of midazolam and propofol on human respiratory cilia beat frequency in vitro

Intensive care medicine, 1998-08, Vol.24 (8), p.791-794

1998

Volltextzugriff (PDF)

Aberrant cerebellar granule cell-specific GABAA receptor expression in the epileptic and ataxic mouse mutant, Tottering

Neuroscience, 2007-08, Vol.148 (1), p.115-125

2007

Volltextzugriff (PDF)

919 ENTECAVIR (ETV) THERAPY IN CHRONIC HEPATITIS B PATIENTS PREVIOUSLY TREATED WITH ADEFOVIR (ADV) WITH INCOMPLETE RESPONSE ON-TREATMENT OR RELAPSE OFF-TREATMENT

Journal of hepatology, 2009, Vol.50, p.S334-S334

2009

Volltextzugriff (PDF)

42 Results of a one-year international phase IIB trial of LDT, and LDT plus lamivudine, in patients with chronic hepatitis B

Journal of hepatology, 2004, Vol.40, p.16-16

2004

Volltextzugriff (PDF)

438 Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB) patients with YMDD variant HBV: 2 year results

Journal of hepatology, 2004, Vol.40, p.130-130

2004

Volltextzugriff (PDF)

439 Improving antiviral therapy in chronic hepatitis B: Maximal viral suppression at week 24 correlates with better clinical efficacy at one year

Journal of hepatology, 2004, Vol.40, p.130-130

2004

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Humans
(5)
Life Sciences & Biomedicine
(4)
Science & Technology
(4)
Biological And Medical Sciences
(3)
Animals
(2)
Biochemistry & Molecular Biology
(2)
Cilia - Drug Effects
(2)
Dna
(2)
Hematology, Oncology And Palliative Medicine
(2)
Medical Sciences
(2)
Mice
(2)
Pharmacology. Drug Treatments
(2)
Radiology
(2)
2.1
(1)
631/67/1612/2143
(1)
Actividad Enzimatica
(1)
Activite Enzymatique
(1)
Adenocarcinoma
(1)
Adn
(1)
Adult
(1)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Epigenetic Analysis of Small Cell Lung Cancer Defines Distinct Disease Subsets

A Prospective Study of FDG-PET Imaging in Assessment of Response to Therapy in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma Undergoing Salvage Chemotherapy and Autologous Stem Cell Transplant

DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2

Impact of TWIST1 Transactivation Domain towards Oncogene-Induced Senescence Suppression in Non-Small Cell Lung Cancer

Investigating the Role of TNIK in the Pathogenesis of Lung Squamous Cell Carcinoma

1787P Intracranial response in patients (pts) with baseline (BL) brain metastases (BM) and extensive-stage (ES) small cell lung cancer (SCLC) treated with ifinatamab deruxtecan (I-DXd) in the IDeate-Lung01 study

P2.16-06 A Phase 2 Study of Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Previously Treated ES-SCLC

1550TiP Phase II, multicenter, randomized, open-label study of DS-7300 in patients (pts) with pre-treated extensive-stage small cell lung cancer (ES-SCLC)

OA04.03 Ifinatamab Deruxtecan (I-DXd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Interim Analysis of Ideate-lung01

Epigenetic Analysis of Small Cell Lung Cancer Defines Distinct Disease Subsets: Small Cell Lung Cancer

Preliminary safety and efficacy of rovalpituzumab tesirine in patients with delta-like protein 3-expressing advanced solid tumors

Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis

Phase I/II Study to Assess the Safety, Pharmacokinetics (PK) and Efficacy of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Carboplatin/Etoposide in Patients with Solid Tumors Including Small-Cell Lung Cancer (SCLC)

1543TiP - Phase I/II Study to Assess the Safety, Pharmacokinetics (PK) and Efficacy of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Carboplatin/Etoposide in Patients with Solid Tumors Including Small-Cell Lung Cancer (SCLC)

Intragenic Suppressors of Mutant DNA Topoisomerase I-induced Lethality Diminish Enzyme Binding of DNA

Recovery of respiratory ciliary function after depression by inhalation anaesthetic agents: an in vitro study using nasal turbinate explants

An investigation into the effects of midazolam and propofol on human respiratory cilia beat frequency in vitro

Aberrant cerebellar granule cell-specific GABAA receptor expression in the epileptic and ataxic mouse mutant, Tottering

919 ENTECAVIR (ETV) THERAPY IN CHRONIC HEPATITIS B PATIENTS PREVIOUSLY TREATED WITH ADEFOVIR (ADV) WITH INCOMPLETE RESPONSE ON-TREATMENT OR RELAPSE OFF-TREATMENT

42 Results of a one-year international phase IIB trial of LDT, and LDT plus lamivudine, in patients with chronic hepatitis B

438 Continued safety and efficacy of adding adefovir dipivoxil (ADV) to ongoing lamivudine (LAM) therapy in compensated chronic hepatitis B (CHB) patients with YMDD variant HBV: 2 year results

439 Improving antiviral therapy in chronic hepatitis B: Maximal viral suppression at week 24 correlates with better clinical efficacy at one year

Suchergebnisse filtern